Watchlist Price Alert

Journey Medical Corporati... (DERM)

NASDAQ: DERM · Real-Time Price · USD

6.55

-0.32 (-4.66%)

At close: May 06, 2025, 3:59 PM

6.82

4.04%

Pre-market: May 07, 2025, 08:27 AM EDT

-4.66% (1D)

Bid	6.41
Market Cap	151.51M
Revenue (ttm)	56.13M
Net Income (ttm)	-14.67M
EPS (ttm)	-0.72
PE Ratio (ttm)	-9.1
Forward PE	11.11
Analyst	Buy

Ask	6.82
Volume	130,830
Avg. Volume (20D)	75,296
Open	6.62
Previous Close	6.87
Day's Range	6.47 - 6.87
52-Week Range	3.20 - 7.84
Beta	0.87

About DERM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DERM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DERM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

8 months ago

+14.22%

Journey Medical shares are trading higher after th... Unlock content with Pro Subscription

News

1 week ago · zacks.com

Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?

Journey Medical (DERM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incr...

4 weeks ago · zacks.com

Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?

Journey Medical (DERM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near t...

1 month ago · seekingalpha.com

Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript

Journey Medical Corporation (NASDAQ:DERM ) Q4 2024 Results Conference Call March 26, 2025 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Found...

1 month ago · zacks.com

Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates

Journey Medical Corporation (DERM) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to loss of $0.12 per share a ye...